FDA Grants Approval for L-Glutamine ANDA219750 by Renova Pharms
The FDA has granted approval for the ANDA219750 application for L-Glutamine submitted by Renova Pharms.
Company
Pharmaceutical intelligence for L-Glutamine with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.